CHI3L1 and Hepatic fibrosis: Using serum CHI3L1 content alone as an indicator to predict the degree of fibrosis is feasible, but the level of CHI3L1 in the liver gradually increases with normal aging, which is unrelated to the existence of liver fibrosis disease (shown in Figure 2).